Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00106522
What this trial is testing

Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 499
Testing effectiveness (Phase 2)Ended earlyNCT01285310
What this trial is testing

Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Amgen 237
Post-approval studies (Phase 4)Looking for participantsNCT07685769
What this trial is testing

Find Out if the Medicine Called Rimegepant is Safe for Adults in India

Who this might be right for
Acute Treatment of Migraine
Pfizer 60
Not applicableStudy completedNCT03842722
What this trial is testing

Insufficient Oxygenation in Septic Patients

Who this might be right for
SepsisCritical CareMitochondria+2 more
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research 81
Large-scale testing (Phase 3)Ended earlyNCT01676701
What this trial is testing

Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 8
Testing effectiveness (Phase 2)Study completedNCT02349451
What this trial is testing

Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)

Who this might be right for
Psoriatic Arthritis
AbbVie 240
Not applicableLooking for participantsNCT07045896
What this trial is testing

Fucoidan in the Treatment of Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07795151
What this trial is testing

Phase I/II Trial of Human Umbilical Cord Mesenchymal Stromal Cells for UDCA-Refractory Primary Biliary Cholangitis

Who this might be right for
Primary Biliary Cholangitis
Beijing 302 Hospital 68
Large-scale testing (Phase 3)Study completedNCT02265705
What this trial is testing

Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 290
Testing effectiveness (Phase 2)Study completedNCT01894516
What this trial is testing

Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 287
Large-scale testing (Phase 3)Study completedNCT04134728
What this trial is testing

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 550
Testing effectiveness (Phase 2)Study completedNCT05460832
What this trial is testing

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Who this might be right for
Rheumatoid Arthritis
Modern Biosciences Ltd 248
Early research (Phase 1)Ended earlyNCT04951609
What this trial is testing

Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 31
Large-scale testing (Phase 3)Study completedNCT03486457
What this trial is testing

Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Pfizer 204
Large-scale testing (Phase 3)Study completedNCT01721044
What this trial is testing

A Moderate to Severe Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 527
Large-scale testing (Phase 3)Study completedNCT00646178
What this trial is testing

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

Who this might be right for
ArthritisPsoriatic
Abbott 102
Post-approval studies (Phase 4)UnknownNCT01341743
What this trial is testing

Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy

Who this might be right for
Hepatitis B
Nanfang Hospital, Southern Medical University 360
Large-scale testing (Phase 3)Study completedNCT01844518
What this trial is testing

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Active Polyarticular Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 219
Testing effectiveness (Phase 2)Study completedNCT01725282
What this trial is testing

Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Astellas Pharma Inc 172
Large-scale testing (Phase 3)Study completedNCT00048568
What this trial is testing

A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,250
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation